Suppr超能文献

R 环介导的单链 DNA 断裂在短期暴露于组蛋白去乙酰化酶抑制剂罗米地辛后积累。

R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.

机构信息

Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, New York.

University of Copenhagen, Copenhagen, Denmark.

出版信息

Mol Cancer Res. 2021 Aug;19(8):1361-1374. doi: 10.1158/1541-7786.MCR-20-0833. Epub 2021 May 28.

Abstract

Histone deacetylase inhibitors (HDACi) induce hyperacetylation of histones by blocking HDAC catalytic sites. Despite regulatory approvals in hematological malignancies, limited solid tumor clinical activity has constrained their potential, arguing for better understanding of mechanisms of action (MOA). Multiple activities of HDACis have been demonstrated, dependent on cell context, beyond the canonical induction of gene expression. Here, using a clinically relevant exposure duration, we established DNA damage as the dominant signature using the NCI-60 cell line database and then focused on the mechanism by which hyperacetylation induces DNA damage. We identified accumulation of DNA-RNA hybrids (R-loops) following romidepsin-induced histone hyperacetylation, with single-stranded DNA (ssDNA) breaks detected by single-cell electrophoresis. Our data suggest that transcription-coupled base excision repair (BER) is involved in resolving ssDNA breaks that, when overwhelmed, evolve to lethal dsDNA breaks. We show that inhibition of BER proteins such as PARP will increase dsDNA breaks in this context. These studies establish accumulation of R-loops as a consequence of romidepsin-mediated histone hyperacetylation. We believe that the insights provided will inform design of more effective combination therapy with HDACis for treatment of solid tumors. IMPLICATIONS: Key HDAC inhibitor mechanisms of action remain unknown; we identify accumulation of DNA-RNA hybrids (R-loops) due to chromatin hyperacetylation that provokes single-stranded DNA damage as a first step toward cell death.

摘要

组蛋白去乙酰化酶抑制剂(HDACi)通过阻断 HDAC 催化位点来诱导组蛋白的超乙酰化。尽管在血液恶性肿瘤中获得了监管批准,但有限的实体瘤临床活性限制了它们的潜力,这表明需要更好地了解作用机制(MOA)。已经证明 HDACi 具有多种活性,这取决于细胞环境,而不仅仅是经典的基因表达诱导。在这里,我们使用临床相关的暴露持续时间,使用 NCI-60 细胞系数据库确定了 DNA 损伤是主要特征,然后专注于组蛋白超乙酰化诱导 DNA 损伤的机制。我们发现,在罗米地辛诱导的组蛋白超乙酰化后,DNA-RNA 杂交(R 环)会积累,通过单细胞电泳检测到单链 DNA(ssDNA)断裂。我们的数据表明,转录偶联的碱基切除修复(BER)参与修复 ssDNA 断裂,当 BER 无法承受时,ssDNA 断裂会演变成致命的双链 DNA 断裂。我们表明,在这种情况下抑制 BER 蛋白(如 PARP)会增加双链 DNA 断裂。这些研究确立了 R 环的积累是罗米地辛介导的组蛋白超乙酰化的结果。我们相信,提供的这些见解将为设计更有效的与 HDACi 的联合治疗方案提供信息,以治疗实体瘤。意义:关键的 HDAC 抑制剂作用机制仍不清楚;我们确定由于染色质超乙酰化导致的 DNA-RNA 杂交(R 环)的积累,这会引发单链 DNA 损伤,作为细胞死亡的第一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1523/8974437/051e070f8d31/molcanres-19-1361-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验